カテゴリー： FactMR, 世界, 医療/バイオ

避妊具の世界市場2023年～2033年：予測・動向・分析・競争状況

◆英語タイトル：Contraceptives Market By Product (Contraceptive Drugs, Contraceptive Devices), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Platforms, Clinics) & By Region (North America, Europe, Asia Pacific) – Global Market Insights 2023 to 2033

FactMRが発行した調査報告書（FACT23AP088）◆商品コード：FACT23AP088
◆発行会社（リサーチ会社）：FactMR
◆発行日：2023年1月31日
◆ページ数：約170
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧、印刷不可）USD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
Global Site License（同一拠点内共有可）USD8,500 ⇒換算￥1,292,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ファクトエムアール社の本調査資料は、2023年から2033年までの世界の避妊具市場の現状・動向について調査した最新レポートです。序論、仮定・調査手法、エグゼクティブサマリー、市場概要、製品別（避妊薬、避妊用注射剤）分析、流通チャネル別（病院薬局、独立系薬局、オンラインプラットフォーム、クリニック、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、競争状況などの構成でまとめております。なお、当レポートには、Merck & Co., Inc.、Allergan plc、Bayer AGなどの企業情報が含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・世界の避妊具市場規模：製品別
　- 避妊薬の市場規模
　- 避妊用注射剤の市場規模
・世界の避妊具市場規模：流通チャネル別
　- 病院薬局の市場規模
　- 独立系薬局の市場規模
　- オンラインプラットフォームの市場規模
　- クリニックの市場規模
　- その他流通チャネルの市場規模
・世界の避妊具市場規模：地域別
　- 北米の避妊具市場規模
　- ヨーロッパの避妊具市場規模
　- アジア太平洋の避妊具市場規模
　- 中南米の避妊具市場規模
　- 中東/アフリカの避妊具市場規模
・競争状況

本資料には、各企業の製品ポートフォリオや主要戦略、包括的なSWOT分析などの要素を含む企業情報が含まれています。企業のプレゼンスは、全著名プレーヤーについてマッピングされ、マトリックスを通して提示されます。また、読者に実用的な洞察を提供し、熟考して市場の状況を示し、避妊具における競争レベルを推測するのに役立ちます。

Contraceptives Market – Scope of Report

A recent study by Fact.MR on the contraceptives market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering contraceptives.

The study also provides the dynamics responsible for influencing the future status of the contraceptives market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the contraceptives market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of contraceptives across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of contraceptives during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for contraceptives are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global contraceptives market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the contraceptives market during the forecast period.

Country-specific valuation on demand for contraceptives has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of contraceptives, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering contraceptives has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the contraceptives domain.

❖ レポートの目次 ❖

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

    3.1. Global Contraceptive Market Size (US$ Mn) and Forecast, by Region, 2023 and 2033

    3.2. Global Contraceptive Market: Market Snapshot

4. Market Overview

    4.1. Global Contraceptive Market Overview

    4.2. Global Contraceptive Market Key Industry Developments

5. Market Dynamics

    5.1. Drivers and Restraints Snapshot Analysis

    5.2. Drivers

    5.3. Restraints

    5.4. Opportunities

    5.5. Key Trends

    5.6. Global Contraceptive Market Revenue Projections (US$ Mn), 2023–2033

    5.7. Regulatory Framework

    5.8. Heat Map Analysis – Company

6. Global Contraceptive Market Analysis, by Product

    6.1. Introduction

    6.2. Key Insights

    6.3. Global Contraceptive Market Size and Forecast, by Product

        6.3.1. Contraceptive Drugs

            6.3.1.1. Oral Contraceptives

                6.3.1.1.1. Combined Contraceptives

                6.3.1.1.2. Mini-pills

            6.3.1.2. Contraceptive Injectable

            6.3.1.3. Topical Contraceptive Patch

        6.3.2. Contraceptive Injectable

            6.3.2.1. Male Contraceptive Devices

            6.3.2.2. Female Contraceptive Devices

                6.3.2.2.1. Female Condoms

                6.3.2.2.2. Contraceptive Diaphragms

                6.3.2.2.3. Contraceptive Sponges

                6.3.2.2.4. Contraceptive Vaginal Rings

                6.3.2.2.5. Intrauterine Devices

                6.3.2.2.6. Sub-dermal Contraceptives Implants

                6.3.2.2.7. Non-Surgical Permanent Contraception Devices

    6.4. Global Contraceptive Market Analysis, by Product

    6.5. Global Contraceptive Market Attractiveness Analysis, by Product

7. Global Contraceptive Market Analysis, by Distribution Channel

    7.1. Introduction

    7.2. Key Insights

    7.3. Global Contraceptive Market Size and Forecast, by Distribution Channel

        7.3.1. Hospital Pharmacy

            7.3.1.1. Public

            7.3.1.2. Private

        7.3.2. Independent Pharmacy

        7.3.3. Online Platform

        7.3.4. Clinics

        7.3.5. Others

    7.4. Global Contraceptive Market Analysis, by Distribution Channel

    7.5. Global Contraceptive Market Attractiveness Analysis, by Distribution Channel

8. Global Contraceptive Market Analysis, by Region

    8.1. Introduction

    8.2. Key Insights

    8.3. Global Contraceptive Market Size and Forecast , by Region, 2018–2033

        8.3.1. North America

        8.3.2. Europe

        8.3.3. Asia Pacific

        8.3.4. Latin America

        8.3.5. Middle East & Africa

    8.4. Global Contraceptive Market Analysis, by Region

    8.5. Global Contraceptive Market Attractiveness Analysis, by Region

9. North America Contraceptive Market Analysis

    9.1. North America Contraceptive Market Key Findings

    9.2. North America Contraceptive Market Overview

    9.3. North America Contraceptive Market Size and Forecast, by Product

        9.3.1. Contraceptive Drugs

            9.3.1.1. Oral Contraceptives

                9.3.1.1.1. Combined Contraceptives

                9.3.1.1.2. Mini-pills

            9.3.1.2. Contraceptive Injectable

            9.3.1.3. Topical Contraceptive Patch

        9.3.2. Contraceptive Injectable

            9.3.2.1. Male Contraceptive Devices

            9.3.2.2. Female Contraceptive Devices

                9.3.2.2.1. Female Condoms

                9.3.2.2.2. Contraceptive Diaphragms

                9.3.2.2.3. Contraceptive Sponges

                9.3.2.2.4. Contraceptive Vaginal Rings

                9.3.2.2.5. Intrauterine Devices

                9.3.2.2.6. Sub-dermal Contraceptives Implants

        9.3.3. Non-Surgical Permanent Contraception Devices

    9.4. North America Contraceptive Market Size and Forecast, by Distribution Channel

        9.4.1. Hospital Pharmacy

            9.4.1.1. Public

            9.4.1.2. Private

        9.4.2. Independent Pharmacy

        9.4.3. Online Platform

        9.4.4. Clinics

        9.4.5. Others

    9.5. North America Contraceptive Market Forecast, by Country

        9.5.1. U.S.

        9.5.2. Canada

    9.6. North America Contraceptive Market Attractiveness Analysis

        9.6.1. By Product

        9.6.2. By Distribution Channel

        9.6.3. By Country

10. Europe Contraceptive Market Analysis

    10.1. Europe Contraceptive Market Key Findings

    10.2. Europe Contraceptive Market Overview

    10.3. Europe Contraceptive Market Size and Forecast, by Product

        10.3.1. Contraceptive Drugs

            10.3.1.1. Oral Contraceptives

                10.3.1.1.1. Combined Contraceptives

                10.3.1.1.2. Mini-pills

            10.3.1.2. Contraceptive Injectable

            10.3.1.3. Topical Contraceptive Patch

        10.3.2. Contraceptive Injectable

            10.3.2.1. Male Contraceptive Devices

            10.3.2.2. Female Contraceptive Devices

                10.3.2.2.1. Female Condoms

                10.3.2.2.2. Contraceptive Diaphragms

                10.3.2.2.3. Contraceptive Sponges

                10.3.2.2.4. Contraceptive Vaginal Rings

                10.3.2.2.5. Intrauterine Devices

                10.3.2.2.6. Sub-dermal Contraceptives Implants

        10.3.3. Non-Surgical Permanent Contraception Devices

    10.4. Europe Contraceptive Market Size and Forecast, by Distribution Channel

        10.4.1. Hospital Pharmacy

            10.4.1.1. Public

            10.4.1.2. Private

        10.4.2. Independent Pharmacy

        10.4.3. Online Platform

        10.4.4. Clinics

        10.4.5. Others

    10.5. Europe Contraceptive Market Forecast, by Country

        10.5.1. Germany

        10.5.2. U.K.

        10.5.3. France

        10.5.4. Spain

        10.5.5. Italy

        10.5.6. Rest of Europe

    10.6. Europe Contraceptive Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Distribution Channel

        10.6.3. By Country

11. Asia Pacific Contraceptive Market Analysis

    11.1. Asia Pacific Contraceptive Market Key Findings

    11.2. Asia Pacific Contraceptive Market Overview

    11.3. Asia Pacific Cytometry Market Size and Forecast, by Product

        11.3.1. Contraceptive Drugs

            11.3.1.1. Oral Contraceptives

                11.3.1.1.1. Combined Contraceptives

                11.3.1.1.2. Mini-pills

            11.3.1.2. Contraceptive Injectable

            11.3.1.3. Topical Contraceptive Patch

        11.3.2. Contraceptive Injectable

            11.3.2.1. Male Contraceptive Devices

            11.3.2.2. Female Contraceptive Devices

                11.3.2.2.1. Female Condoms

                11.3.2.2.2. Contraceptive Diaphragms

                11.3.2.2.3. Contraceptive Sponges

                11.3.2.2.4. Contraceptive Vaginal Rings

                11.3.2.2.5. Intrauterine Devices

                11.3.2.2.6. Sub-dermal Contraceptives Implants

        11.3.3. Non-Surgical Permanent Contraception Devices

    11.4. Asia Pacific Contraceptive Market Size and Forecast, by Distribution Channel

        11.4.1. Hospital Pharmacy

            11.4.1.1. Public

            11.4.1.2. Private

        11.4.2. Independent Pharmacy

        11.4.3. Online Platform

        11.4.4. Clinics

        11.4.5. Others

    11.5. Asia Pacific Contraceptive Market Forecast, by Country

        11.5.1. China

        11.5.2. India

        11.5.3. Japan

        11.5.4. Australia & New Zealand

        11.5.5. Rest of Asia Pacific

    11.6. Asia Pacific Contraceptive Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Distribution Channel

        11.6.3. By Country

12. Latin America Contraceptive Market Analysis

    12.1. Latin America Contraceptive Market Key Findings

    12.2. Latin America Contraceptive Market Overview

    12.3. Latin America Cytometry Market Size and Forecast, by Product

        12.3.1. Contraceptive Drugs

            12.3.1.1. Oral Contraceptives

                12.3.1.1.1. Combined Contraceptives

                12.3.1.1.2. Mini-pills

            12.3.1.2. Contraceptive Injectable

            12.3.1.3. Topical Contraceptive Patch

        12.3.2. Contraceptive Injectable

            12.3.2.1. Male Contraceptive Devices

            12.3.2.2. Female Contraceptive Devices

                12.3.2.2.1. Female Condoms

                12.3.2.2.2. Contraceptive Diaphragms

                12.3.2.2.3. Contraceptive Sponges

                12.3.2.2.4. Contraceptive Vaginal Rings

                12.3.2.2.5. Intrauterine Devices

                12.3.2.2.6. Sub-dermal Contraceptives Implants

        12.3.3. Non-Surgical Permanent Contraception Devices

    12.4. Latin America Contraceptive Market Size and Forecast, by Distribution Channel

        12.4.1. Hospital Pharmacy

            12.4.1.1. Public

            12.4.1.2. Private

        12.4.2. Independent Pharmacy

        12.4.3. Online Platform

        12.4.4. Clinics

        12.4.5. Others

    12.5. Latin America Contraceptive Market Forecast, by Country

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Latin America Contraceptive Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Distribution Channel

        12.6.3. By Country

13. Middle East & Africa Contraceptive Market Analysis

    13.1. Middle East & Africa Contraceptive Market Key Findings

    13.2. Middle East & Africa Contraceptive Market Overview

    13.3. Middle East & Africa Cytometry Market Size and Forecast, by Product

        13.3.1. Contraceptive Drugs

            13.3.1.1. Oral Contraceptives

                13.3.1.1.1. Combined Contraceptives

                13.3.1.1.2. Mini-pills

            13.3.1.2. Contraceptive Injectable

            13.3.1.3. Topical Contraceptive Patch

        13.3.2. Contraceptive Injectable

            13.3.2.1. Male Contraceptive Devices

            13.3.2.2. Female Contraceptive Devices

                13.3.2.2.1. Female Condoms

                13.3.2.2.2. Contraceptive Diaphragms

                13.3.2.2.3. Contraceptive Sponges

                13.3.2.2.4. Contraceptive Vaginal Rings

                13.3.2.2.5. Intrauterine Devices

                13.3.2.2.6. Sub-dermal Contraceptives Implants

        13.3.3. Non-Surgical Permanent Contraception Devices

    13.4. Middle East & Africa Contraceptive Market Size and Forecast, by Distribution Channel

        13.4.1. Hospital Pharmacy

            13.4.1.1. Public

            13.4.1.2. Private

        13.4.2. Independent Pharmacy

        13.4.3. Online Platform

        13.4.4. Clinics

        13.4.5. Others

    13.5. Middle East Contraceptive Market Forecast, by Country

        13.5.1. South Africa

        13.5.2. Saudi Arabia

        13.5.3. U.A.E.

        13.5.4. Rest of Middle East & Africa

    13.6. Middle East Contraceptive Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Distribution Channel

        13.6.3. By Country

14. Competition Landscape

    14.1. Global Contraceptive Market Share Analysis, by Company (2022)

    14.2. Company Profiles

        14.2.1. Merck & Co., Inc.

            14.2.1.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.1.2. Financials

            14.2.1.3. Recent Developments

            14.2.1.4. Strategy

        14.2.2. Cipla Inc.

            14.2.2.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.2.2. Financials

            14.2.2.3. Recent Developments

            14.2.2.4. Strategy

        14.2.3. Allergan plc

            14.2.3.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.3.2. Financials

            14.2.3.3. Recent Developments

            14.2.3.4. Strategy

        14.2.4. Bayer AG

            14.2.4.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.4.2. Financials

            14.2.4.3. Recent Developments

            14.2.4.4. Strategy

        14.2.5. HLL Lifecare Limited

            14.2.5.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.5.2. Financials

            14.2.5.3. Recent Developments

            14.2.5.4. Strategy

        14.2.6. Mankind Pharma

            14.2.6.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.6.2. Financials

            14.2.6.3. Recent Developments

            14.2.6.4. Strategy

        14.2.7. Pfizer, Inc.

            14.2.7.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.7.2. Financials

            14.2.7.3. Recent Developments

            14.2.7.4. Strategy

        14.2.8. Teva Pharmaceutical Industries Ltd l

            14.2.8.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.8.2. Financials

            14.2.8.3. Recent Developments

            14.2.8.4. Strategy

        14.2.9. Mithra Pharmaceuticals

            14.2.9.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.9.2. Financials

            14.2.9.3. Recent Developments

            14.2.9.4. Strategy

        14.2.10. Janssen Pharmaceutical Company

            14.2.10.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.10.2. Financials

            14.2.10.3. Recent Developments

            14.2.10.4. Strategy

        14.2.11. Reckitt Benckiser Group plc

            14.2.11.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.11.2. Financials

            14.2.11.3. Recent Developments

            14.2.11.4. Strategy

Table 01: Global Market Size (US$ Mn) Forecast, by Product Type, 2023–2033

Table 02: Global Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2023–2033

Table 03: Global Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023–2033

Table 04: Global Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2023–2033

Table 05: Global Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2023–2033

Table 06: Global Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033

Table 07: Global Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023–2033

Table 08: Global Market Size (US$ Mn) Forecast, by Region, 2023–2033

Table 09: North America Market Size (US$ Mn) Forecast, by Country, 2023–2033

Table 10: North America Market Size (US$ Mn) Forecast, by Product Type, 2023–2033

Table 11: North America Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2023–2033

Table 12: North America Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023–2033

Table 13: North America Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2023–2033

Table 14: North America Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2023–2033

Table 15: North America Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033

Table 16: North America Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023–2033

Table 17: Europe Market Size (US$ Mn) Forecast, by Country, 2023–2033

Table 18: Europe Market Size (US$ Mn) Forecast, by Product Type, 2023–2033

Table 19: Europe Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2023–2033

Table 20: Europe Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023–2033

Table 21: Europe Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2023–2033

Table 22: Europe Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2023–2033

Table 23: Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033

Table 24: Europe Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023–2033

Table 25: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2023–2033

Table 26: Asia Pacific Market Size (US$ Mn) Forecast, by Product Type, 2023–2033

Table 27: Asia Pacific Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2023–2033

Table 28: Asia Pacific Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023–2033

Table 29: Asia Pacific Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2023–2033

Table 30: Asia Pacific Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2023–2033

Table 31: Asia Pacific Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033

Table 32: Asia Pacific Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023–2033

Table 33: Latin America Market Size (US$ Mn) Forecast, by Country, 2023–2033

Table 34: Latin America Market Size (US$ Mn) Forecast, by Product Type, 2023–2033

Table 35: Latin America Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2023–2033

Table 36: Latin America Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023–2033

Table 37: Latin America Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2023–2033

Table 38: Latin America Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2023–2033

Table 39: Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033

Table 40: Latin America Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023–2033

Table 41: Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2023–2033

Table 42: Middle East & Africa Market Size (US$ Mn) Forecast, by Product Type, 2023–2033

Table 43: Middle East & Africa Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2023–2033

Table 44: Middle East & Africa Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023–2033

Table 45: Middle East & Africa Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2023–2033

Table 46: Middle East & Africa Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2023–2033

Table 47: Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033

Table 48: Middle East & Africa Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023–2033

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 避妊具の世界市場2023年～2033年：予測・動向・分析・競争状況(Contraceptives Market By Product (Contraceptive Drugs, Contraceptive Devices), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Platforms, Clinics) & By Region (North America, Europe, Asia Pacific) – Global Market Insights 2023 to 2033)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 女性用避妊薬の世界市場2022年～2029年：避妊薬別、デバイス別、地域別
  • ホルモン避妊薬の世界市場予測（～2030）
  • 世界の注射用避妊薬市場2023年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆